Treatment of aromatase inhibitors in severe poor responder patients: matched comparison with non-treated previous cycles in same patients

Chung, Myung-Jin; Ryu, Mi Jin; Kim, H.S.; Kim, M.H.; Jeong, Hae Kyung; Lee, H.S.

doi:10.1016/j.fertnstert.2014.07.225

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the literature, there are different studies with conflicting results, some showed that adding letrozole decreased the doses of HMG and days of stimulation (Lee, Kyung-Hee, et al) [21] , others found significant increase in oocytes numbers and no significant increase in fertilization rate with letrozole group(Chung et al) [22] , (Ozmen et al) found that adding letrozole had benefits in improving the success of ovarian stimulation cycles by decreasing cycle cancellation rate. [23] (Mahbod Ebrahimi et al) found no significant difference regarding implantation rate after giving aromatase inhibitors to their patients.…”

Section: Discussionmentioning

confidence: 99%

Study of the Effect of Adding Letrozole to Gonadotropin-Releasing Hormone Antagonist Protocol in Poor Responders Undergoing Intracytoplasmic Sperm Injection

sharkawy

Abdraboo

Elabd

et al. 2021

Evidence Based Women's Health Journal

View full text Add to dashboard Cite

Background: Poor responders constitute a less fortunate group of patients attending any IVF/ICSI clinic. Identifying these patients helps in choosing the most appropriate stimulation protocol. Aim:This is a randomized controlled prospective study that aimed to study the effect of adding letrozole to GnRH antagonist protocol in poor responders undergoing ICSI. Materials and Methods: This study was carried out on a sample of 70 infertile couple, thirty five patients in each group, five cases were canceled in group I (letrozole/antagonist group), while six patients in group II (antagonist group) canceled the cycle. In group I, letrozole 5mg was given from day 2 cycle for 5 days. Initial dose of HMG 300 I.U from day three cycle, then the dose was modulated according to response in both groups and ICSI was done. The women were followed to detect the occurrence of pregnancy by measuring serum B-hCG 14 day after embryo transfer and clinical pregnancy was followed up at 6th week of gestation. Results: The dose of HMG was significantly lower in group I than in group II, while there were no significant statistical differences in the duration of stimulation, number of oocytes retrieved, fertilization rate, implantation rate, cycle cancelation rate, and clinical pregnancy rate with adding letrozole to GnRH antagonist cycles in women with POR. Conclusion:Letrozole is recommended to be added to ICSI stimulation protocols in poor responders. Although it didn't affect the pregnancy rate, letrozole decreases the dose and the cost of ICSI cycles.

show abstract

Section: Discussionmentioning

confidence: 99%